Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 9Sexual Dysfunction, Physiological 1Non-Small Cell Lung Cancer ALK-positive 1Neuroblastoma 1Neoplasm Metastasis 1Meningeal Carcinomatosis 1Lung Neoplasms 1Lung Diseases 1Hyperlipidemias 1Eunuchism 1Erectile Dysfunction 1Brain Neoplasms 1ALK-positive Non-small Cell Lung Cancer 1ALK-positive NSCLC 1

Interventions

Polymerase Chain Reaction 6Gene Expression Profiling 5Amplified Fragment Length Polymorphism Analysis 5Immunohistochemistry 4Flow Cytometry 4Blotting, Western 3Microarray Analysis 2Enzyme-Linked Immunosorbent Assay 2Data Collection 2naxitamab 1lorlatinib 1dinutuximab 1Tumor Burden 1Psychiatric Rehabilitation 1Prospective Studies 1Phlebotomy 1Microscopy 1Mass Spectrometry 1In Situ Hybridization, Fluorescence 1Immunosuppression Therapy 1Immunologic Techniques 1Immunoenzyme Techniques 1Gene Rearrangement 1Follow-Up Studies 1Electrophoresis, Polyacrylamide Gel 1DNA Methylation 1Cytogenetic Analysis 1Comparative Genomic Hybridization 1Chromatography, Liquid 1Cancer Vaccines 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Neuroblastoma × lorlatinib × Clear all
NCT04753658 2024-09-23

Real World Data Collection Pediatric Neuroblastoma Treated With Lorlatinib

Pfizer

Terminated
15 enrolled 22 charts
CNS

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡